ClinicalTrials.gg
Not yet recruitingNCT06467422Updated Jun 21, 2024

Effects of Transcranial Temporal Interference Stimulation on Risky Decision-making and Impulse Control in Gambling Disorder

An interventional study of tTIS on dACC, theta frequency (5 Hz) and tTIS on dACC, High frequency in Gambling Disorder, sponsored by Shanghai Mental Health Center. Not yet recruiting at 1 site in China. Open to male participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-06-21.

Sponsored by Shanghai Mental Health Center · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Male
01

Study summary

The purpose of this research is to investigate the effect of transcranial temporal interference stimulation (tTIS) targeting the dorsal anterior cingulate cortex in patients with gambling disorder.

Read the detailed description

This study will apply the emerging non-invasive deep brain stimulation of tTIS to the dorsal anterior cingulate cortex in a randomized, double-blind design to demonstrate the possibility of non-invasively targeting the anterior cingulate cortex to modulate impulse control and risky decision-making without activating other regions below the electrodes. Additionally, this study will combine the fMRI recordings to describe local and network effects on brain activity. Specifically, each participant will be assessed at baseline with a scale and T1WI sequence and diffusion tensor imaging, and will randomly receive a combination of stimulation sequentially during the intervention phase, with more than a one-week interval ensuring that there is no interference between each of the two stimulation sequences.

02

Conditions studied

  • Gambling Disorder

Browse trials for

03

In context

Gambling

158 studies on the registry are indexed under Gambling; 42 are open to participants now.

This study's planned enrollment of 30 is below the median of 66 across 128 interventional studies indexed under Gambling.

Browse Gambling studies →

Lead sponsor

Shanghai Mental Health Center is the lead sponsor of 272 studies on the registry; 91 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-60, male or female, right handed;
  • With 9 or more years of education, and able to cooperate in completing the questionnaire assessment and behavioural tests.
  • Meets the diagnostic criteria for gambling addiction;
  • Previous gambling behaviour of not less than 1 year's duration (at least one gambling session per week or more);
  • Normal or corrected normal vision and hearing;
  • Agrees to cooperate in completing the follow-up assessment;
  • No history of neurological problems or head injury; and no skin sensitivity.
  • Agree to cooperate in completing the follow-up assessment;
  • No metal implantation in the head, no history of neurological problems or head injury, and no skin sensitivity.

Exclusion criteria

Exclusion Criteria:

  • Suffering from severe cognitive dysfunction, such as a history of head trauma, cerebrovascular disease, epilepsy, etc., use of cognitive-promoting medications in the last 6 months;
  • Other psychoactive substance abuse or dependence in the last 5 years (except nicotine).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Theta Stimulation(6Hz, generated with electrodes of 2kHz and 2.005kHz)

    Session1#T1(10min)+DTI(15min) Session2#rsfMRI(8min)+rsfMRI-Theta tTIs(8min)+rsfMRI(8min)+TASK fMRI-Theta TI(20min)

    Device: tTIS on dACC, theta frequency (5 Hz)

  • Sham comparator
    High Frequency Stimulation(generated with two electrodes of 2kHz)

    Session1#T1(10min)+DTI(15min) Session2#rsfMRI(8min)+rsfMRI-HF tTIs(8min)+rsfMRI(8min)+TASK fMRI-HF TI(20min)

    Device: tTIS on dACC, High frequency

Interventions

  • DevicetTIS on dACC, theta frequency (5 Hz)

    Device: Transcranial electric stimulation device The first pair of electrodes continuously outputs a current with a frequency of f1 = 2 kHz, while the second pair continuously outputs a current with a frequency of f2 = 2.006 kHz. According to the principle of time-domain coherence, an alternating electric field with a frequency of f2-f1 = 6 Hz can be generated in the target area. The experimental group receives a stimulation intensity of 2mA for 20 minutes. The optimal electrode position and current parameters are determined by using the MIDA head electric field model.

  • DevicetTIS on dACC, High frequency

    The first pair of electrodes continuously outputs a current with a frequency of f1 = 2 kHz, while the second pair continuously outputs a current with a frequency of f2 = 2 kHz. The sham group receives a stimulation intensity of 2mA for 20 minutes. The optimal electrode position and current parameters are determined by using the MIDA head electric field model.

06

What researchers measure

Primary outcomes

  1. Activation of dACC

    Activation of dACC is measured with resting-state fMRI and task fMRI.

    Time frame: Through the fMRI procedure

  2. Activation of decision-making network

    Activation of decision-making network is measured with resting-state fMRI and task fMRI connectivity analysis.

    Time frame: Through the fMRI procedure

  3. The change of impulsivity

    The change of impulsivity will be measured by sequential decision-making task.

    Time frame: Through the last 20 minutes of the fMRI session.

Secondary outcomes

  1. The change of gambling craving

    Gambling craving will be measured by the gambling craving Visual Analog Scale (VAS). The total score of VAS ranged from 0 to 10, in which higher scores mean a higher level of gambling craving.

    Time frame: 8 minutes, 16 minutes, 24 minutes, 44 minutes of the fMRI session.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06467422
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Jun 20, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Jun 21, 2024

Study contacts

Tianzhen Chen, M.D, Ph.D
Contact
vomchan@hotmail.com
021-34773523
Min Zhao, M.D, Ph.D
study chair · Shanghai Mental Health Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion